Home LiteratureArticle Details
PMID: 57464 Published · ppublish English Comparative Study Journal Article

Protection by pertussis vaccine. Little cause for concern.

Lancet (London, England) ·Vol. 1 ·No. 7968 ·1976-05-15 ·Pages 1065-7

Preston NW

Abstract

It was estimated from a survey of 418 children aged three weeks to twelve years with bacteriologically confirmed whooping-cough that about 95% of vaccinated children are protected by current vaccine. Protection could be increased even further by the greater use of adsorbed rather than plain vaccine and by closer adherence to a vaccination schedule. The lower incidence of infection, resulting from widespread acceptance of this highly effective vaccine, would also greatly reduce the exposure of infants who are too young to be immunished themselves; and eradication ow whooping-cough would be in sight.

MeSH Terms
Bordetella pertussis/isolation & purification Brain Injuries/diagnosis Child Child, Preschool Disease Outbreaks England Humans Immunity, Active Infant Pertussis Vaccine/administration & dosage,therapeutic use Serotyping Vaccination Whooping Cough/microbiology,prevention & control
Chemicals
Pertussis Vaccine
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Preston N W
Article Info
Journal
Lancet (London, England)
Abbr.
Lancet
ISSN
0140-6736
Published
1976-05-15
Pages
1065-7
Language
English
Region
England
NLM ID
2985213R
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com